Roche 'confident' Spark Therapeutics deal will be completed in 2019, CEO says
Roche is "confident" that it will complete its proposed acquisition of Spark Therapeutics in 2019, the company’s chief executive officer said.Roche is confident that it will complete its proposed acquisition of...To view the full article, register now.
Already a subscriber? Click here to view full article